MONTALTO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 32.922
EU - Europa 19.970
AS - Asia 13.367
SA - Sud America 2.093
Continente sconosciuto - Info sul continente non disponibili 1.654
AF - Africa 426
OC - Oceania 60
Totale 70.492
Nazione #
US - Stati Uniti d'America 32.360
IT - Italia 6.893
SG - Singapore 4.770
RU - Federazione Russa 4.162
CN - Cina 3.533
FI - Finlandia 1.757
BR - Brasile 1.630
DE - Germania 1.416
UA - Ucraina 1.386
VN - Vietnam 1.307
HK - Hong Kong 1.295
PL - Polonia 888
FR - Francia 750
IE - Irlanda 717
GB - Regno Unito 715
JP - Giappone 484
SE - Svezia 395
BD - Bangladesh 374
KR - Corea 306
IN - India 285
CA - Canada 248
NL - Olanda 232
TR - Turchia 163
AR - Argentina 137
RO - Romania 130
BE - Belgio 129
MX - Messico 126
IQ - Iraq 113
CI - Costa d'Avorio 104
ES - Italia 89
UZ - Uzbekistan 85
AT - Austria 78
ZA - Sudafrica 76
VE - Venezuela 75
PK - Pakistan 72
CO - Colombia 70
IR - Iran 68
ID - Indonesia 67
EC - Ecuador 63
MA - Marocco 54
EG - Egitto 48
AU - Australia 46
MY - Malesia 45
PH - Filippine 45
KE - Kenya 39
CL - Cile 38
AE - Emirati Arabi Uniti 37
SA - Arabia Saudita 37
CH - Svizzera 36
JM - Giamaica 35
NP - Nepal 33
GR - Grecia 32
LB - Libano 32
TH - Thailandia 32
CR - Costa Rica 31
DZ - Algeria 31
HN - Honduras 31
AZ - Azerbaigian 25
JO - Giordania 24
PY - Paraguay 24
BG - Bulgaria 23
TN - Tunisia 23
CZ - Repubblica Ceca 22
KZ - Kazakistan 21
LT - Lituania 21
PE - Perù 21
IL - Israele 20
AL - Albania 18
RS - Serbia 18
BO - Bolivia 16
DO - Repubblica Dominicana 16
TW - Taiwan 16
UY - Uruguay 16
NZ - Nuova Zelanda 14
NI - Nicaragua 13
SV - El Salvador 13
ET - Etiopia 12
GT - Guatemala 12
EU - Europa 11
OM - Oman 11
PS - Palestinian Territory 10
BB - Barbados 9
SN - Senegal 9
KG - Kirghizistan 8
PA - Panama 8
TT - Trinidad e Tobago 8
DK - Danimarca 7
GE - Georgia 7
HU - Ungheria 7
PT - Portogallo 7
AM - Armenia 6
BH - Bahrain 6
EE - Estonia 6
KH - Cambogia 6
NO - Norvegia 6
SY - Repubblica araba siriana 6
XK - ???statistics.table.value.countryCode.XK??? 6
HR - Croazia 5
LU - Lussemburgo 5
NG - Nigeria 5
Totale 68.777
Città #
Ashburn 3.799
Fairfield 3.540
Singapore 3.148
San Jose 2.019
Chandler 1.966
Woodbridge 1.732
Houston 1.613
Wilmington 1.556
Seattle 1.366
Hong Kong 1.251
Cambridge 1.211
Ann Arbor 1.176
Zgierz 773
Dublin 710
Moscow 704
Jacksonville 693
Medford 619
Des Moines 564
Beijing 563
Palermo 519
Tokyo 462
Milan 451
Ho Chi Minh City 444
Santa Clara 444
Nanjing 424
New York 417
Los Angeles 397
Princeton 396
Council Bluffs 395
Altamura 392
Dallas 384
Frankfurt am Main 380
Lauterbourg 348
Rome 308
Boardman 304
Hanoi 299
Dearborn 287
Lawrence 268
San Diego 241
The Dalles 229
Helsinki 205
Tulsa 202
Buffalo 171
Naples 165
Nanchang 158
São Paulo 156
Chicago 154
Shenyang 153
Jinan 140
Changsha 138
Hefei 134
Hebei 133
Brussels 119
Orem 116
Tianjin 114
Abidjan 104
London 101
Columbus 97
Munich 89
Falls Church 79
Ludwigshafen am Rhein 78
Nuremberg 78
Da Nang 77
Jiaxing 77
Amsterdam 74
Phoenix 74
Verona 74
Seongnam 71
Florence 70
Venice 70
Ningbo 66
Guangzhou 65
Bologna 64
Brooklyn 63
Redwood City 60
Tashkent 58
Toronto 58
Zhengzhou 58
Saint Petersburg 57
Turin 57
Warsaw 56
Denver 55
Atlanta 54
San Paolo di Civitate 54
Izmir 52
Chennai 51
Hangzhou 49
Montreal 49
Haiphong 47
Johannesburg 47
Rio de Janeiro 47
Shanghai 44
Baghdad 42
Washington 41
Manchester 40
Paris 40
Catania 39
Taizhou 39
Kumar 38
Bremen 37
Totale 41.790
Nome #
Nodulo epatico ipovascolare: ruolo dell’ecografia nella diagnosi di HCC 4.279
A phenobarbital overdose: a case report 405
ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES 393
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 320
Valore predittivo dei test sierologici nella diagnosi di malattia celiaca 316
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 307
Cytochrome P450 2E1 variable number tandem repeat polymorphisms and health risks: A genotype-phenotype study in cancers associated with drinking and/or smoking 287
Hepatocellular carcinoma: Comparison of two different periods at the same center 283
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 281
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review 280
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 279
Low-grade fever: how to distinguish organic from non-organic forms. 267
Serological Pattern of Hepatitis B, C, and HIV Infections Among Immigrants in Sicily: Epidemiological Aspects and Implication on Public Health 266
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 264
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 261
A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease 258
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 256
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects 251
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 251
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 250
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 249
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 248
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 248
Perihepatic limph nodes and anti-viral response in chronic HCV-associated hepatitis 247
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 247
Encefalopatia iponatriemica in peritonite batterica spontanea in soggetto con cirrosi epatica scompensata. 246
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 246
Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients 245
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 245
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children 243
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 243
The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine 241
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells 240
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 239
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 238
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 236
Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-a, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma 235
Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis. 234
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 234
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 234
Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection 233
Serum low density lipoprotein subclasses in asthma 233
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 232
Clinical anatomic, immunomorphologic and molecular anatomic data suggest interplay of thyroidal molecules, autoantibodies and Hsp60 in Hashimoto’s disease 231
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 231
Solitary necrotic nodule of the liver: different pathological findings express a different histogenesis 230
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 230
Genetic determined down regulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 230
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 230
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 227
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 226
CYP2E1 VNTR polymorphisms and hepatocarcinoma: a gender-specific correlation 226
Food allergy in gastroenterologic diseases: review of literature 224
Abnormal liver function in brucellosis 224
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 223
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 222
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 222
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 221
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 220
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 219
Concomitant inflammatory pseudotumor of the liver and spleen 219
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. 218
Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis 218
Sex hormones and risk of liver tumor 217
Relazione tra linfoadenopatia del legamento epatoduodenale e risposta alla terapia anti-virale in pazienti con epatite cronica HCV-correlata 216
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 215
Screening for autoantibodies to tissue transglutaminase reveals a low prevalence of celiac disease in blood donors with cryptogenic hypertransaminasemia 214
Interessamento epatico in corso di febbre bottonosa del Mediterraneo 213
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 212
Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy. 212
Basi fisiopatologiche dell'encefalopatia minima del cirrotico 211
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 211
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 210
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. 209
Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis 209
Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C 209
Assessment of a qualitative serological assay to screen for allergic sensitization in elderly subjects 208
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 208
DRUG INDUCED LIVER INJURIES BY TICAGRELORSTATINS INTERACTION: A CASE REPORT 208
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation 208
Affidabilità del bright liver nella steatosi epatica in soggetti con ipertransaminasemia criptogenetica e con epatopatia da virus C 207
Percutaneous liver biopsy: A safe outpatient procedure? 206
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 205
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 205
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 204
Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment 204
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial 202
Il bright liver echopattern come strumento diagnostico non invasivo di steatosi nell'ipertransaminasemia criptogenetica 202
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 202
PREVALENCE OF LIVER DISEASES IN A POPULATION OF IMMIGRANTS IN SICILY. ANALYSIS OF DAY-HOSPITAL ADMISSIONS IN A DEPARTMENT OF MIGRATION MEDICINE 202
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 202
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells 201
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 200
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 200
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 200
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 200
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 200
Hepatitis C virus infection in hemodialyzed patients 199
Association between single nucleotide polymorphisms (SNPs) of IL-6, TNF-alpha and VEGF-A genes, and susceptibility to hepatocellular carcinoma (HCC) 199
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 199
Totale 27.410
Categoria #
all - tutte 229.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 229.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.460 0 919 135 210 174 200 194 301 591 614 274 848
2022/20236.351 641 1.110 100 604 649 923 468 501 654 102 339 260
2023/20244.007 226 519 259 383 333 608 326 268 81 344 218 442
2024/20257.522 253 620 491 790 366 300 487 454 624 743 968 1.426
2025/202622.751 1.542 695 1.220 1.694 2.108 3.246 3.223 2.446 1.840 2.958 839 940
2026/20271.790 1.153 637 0 0 0 0 0 0 0 0 0 0
Totale 70.492